Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
Articolo
Data di Pubblicazione:
2021
Abstract:
To evaluate 6-month effectiveness of ustekinumab versus tumour necrosis factor inhibitor (TNFi), analysing predictors of low disease activity (LDA)/remission.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
arthritis; biological therapy; psoriatic; therapeutics; Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cohort Studies; Female; Humans; Interleukin-12; Interleukin-23; Male; Middle Aged; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab
Elenco autori:
Smolen, Josef S; Siebert, Stefan; Korotaeva, Tatiana V; Selmi, Carlo; Bergmans, Paul; Gremese, Elisa; Joven-Ibáñez, Beatriz; Katsifis, Gkikas; Noël, Wim; Nurmohamed, Michael T; Richette, Pascal; Sfikakis, Petros P; de Vlam, Kurt; Theander, Elke; Gossec, Laure
Link alla scheda completa:
Link al Full Text:
Pubblicato in: